Ironwood Pharmaceuticals (IRWD) Capital Leases (2010 - 2018)

Ironwood Pharmaceuticals (IRWD) has 9 years of Capital Leases data on file, last reported at $158000.0 in Q4 2018.

• For the quarter ending Q4 2018, Capital Leases changed N/A year-over-year to $158000.0; the trailing twelve-month figure through Dec 2018 stood at $158000.0 (changed N/A YoY), and the FY2018 full-year result was $158000.0, changed N/A from the prior year.
• Capital Leases grew to $158000.0 in Q4 2018, from $21000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $3.2 million in Q2 2014 to a low of $21000.0 in Q1 2017.
• A 5-year average of $1.3 million and a median of $687000.0 in 2015 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases surged 1494.95% in 2014 and tumbled 91.7% in 2017, its largest moves.
• Tracing IRWD's Capital Leases over 5 years: stood at $2.6 million in 2014, then sank by 88.1% to $306000.0 in 2015, then plunged by 73.2% to $82000.0 in 2016, then slumped by 74.39% to $21000.0 in 2017, then soared by 652.38% to $158000.0 in 2018.
• Business Quant data shows IRWD's Capital Leases at $158000.0 in Q4 2018, $21000.0 in Q1 2017, and $82000.0 in Q4 2016.